Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $3.28 Million - $3.69 Million
-55,247 Closed
0 $0
Q4 2020

Feb 11, 2021

SELL
$57.74 - $65.43 $163,230 - $184,970
-2,827 Reduced 4.87%
55,247 $3.43 Million
Q3 2020

Nov 13, 2020

SELL
$57.43 - $63.64 $8,384 - $9,291
-146 Reduced 0.25%
58,074 $3.5 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $124,879 - $145,997
2,278 Added 4.07%
58,220 $3.42 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $9,419 - $13,688
-203 Reduced 0.36%
55,942 $3.12 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $2.76 Million - $3.6 Million
56,145 New
56,145 $3.6 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Horizon Investment Services, LLC Portfolio

Follow Horizon Investment Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investment Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investment Services, LLC with notifications on news.